• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VarEPS:一种用于评估和预警 SARS-CoV-2 基因组已知和虚拟变异的系统。

VarEPS: an evaluation and prewarning system of known and virtual variations of SARS-CoV-2 genomes.

机构信息

Microbial Resource and Big Data Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.

Chinese National Microbiology Data Center (NMDC), Beijing 100101, China.

出版信息

Nucleic Acids Res. 2022 Jan 7;50(D1):D888-D897. doi: 10.1093/nar/gkab921.

DOI:10.1093/nar/gkab921
PMID:34634813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8728250/
Abstract

The genomic variations of SARS-CoV-2 continue to emerge and spread worldwide. Some mutant strains show increased transmissibility and virulence, which may cause reduced protection provided by vaccines. Thus, it is necessary to continuously monitor and analyze the genomic variations of SARS-COV-2 genomes. We established an evaluation and prewarning system, SARS-CoV-2 variations evaluation and prewarning system (VarEPS), including known and virtual mutations of SARS-CoV-2 genomes to achieve rapid evaluation of the risks posed by mutant strains. From the perspective of genomics and structural biology, the database comprehensively analyzes the effects of known variations and virtual variations on physicochemical properties, translation efficiency, secondary structure, and binding capacity of ACE2 and neutralizing antibodies. An AI-based algorithm was used to verify the effectiveness of these genomics and structural biology characteristic quantities for risk prediction. This classifier could be further used to group viral strains by their transmissibility and affinity to neutralizing antibodies. This unique resource makes it possible to quickly evaluate the variation risks of key sites, and guide the research and development of vaccines and drugs. The database is freely accessible at www.nmdc.cn/ncovn.

摘要

SARS-CoV-2 的基因组变异不断出现并在全球范围内传播。一些突变株表现出更高的传染性和毒力,这可能导致疫苗提供的保护作用降低。因此,有必要持续监测和分析 SARS-CoV-2 基因组的基因组变异情况。我们建立了一个评估和预警系统,即 SARS-CoV-2 变异评估和预警系统(VarEPS),包括 SARS-CoV-2 基因组的已知和虚拟突变,以实现对突变株所带来风险的快速评估。从基因组学和结构生物学的角度来看,该数据库全面分析了已知变异和虚拟变异对 ACE2 和中和抗体的理化性质、翻译效率、二级结构和结合能力的影响。基于人工智能的算法用于验证这些基因组学和结构生物学特征量在风险预测中的有效性。这个分类器可以进一步用于根据传染性和对中和抗体的亲和力对病毒株进行分组。这个独特的资源使得快速评估关键位点的变异风险成为可能,并为疫苗和药物的研发提供指导。该数据库可在 www.nmdc.cn/ncovn 免费获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/9c9a4959b918/gkab921fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/a5999c10419a/gkab921fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/25845fa4b034/gkab921fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/8287c54a151d/gkab921fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/77a1d4e2e03c/gkab921fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/241c467c5cc2/gkab921fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/9c9a4959b918/gkab921fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/a5999c10419a/gkab921fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/25845fa4b034/gkab921fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/8287c54a151d/gkab921fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/77a1d4e2e03c/gkab921fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/241c467c5cc2/gkab921fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62c/8728250/9c9a4959b918/gkab921fig6.jpg

相似文献

1
VarEPS: an evaluation and prewarning system of known and virtual variations of SARS-CoV-2 genomes.VarEPS:一种用于评估和预警 SARS-CoV-2 基因组已知和虚拟变异的系统。
Nucleic Acids Res. 2022 Jan 7;50(D1):D888-D897. doi: 10.1093/nar/gkab921.
2
Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach.SARS-CoV-2 S 蛋白 D614G 变异体与中和抗体相互作用的分子特征:一种计算方法。
Infect Genet Evol. 2021 Jul;91:104815. doi: 10.1016/j.meegid.2021.104815. Epub 2021 Mar 24.
3
Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential.SARS-CoV-2 刺突蛋白 N 端结构域中的突变热点赋予免疫逃逸潜能。
Viruses. 2021 Oct 20;13(11):2114. doi: 10.3390/v13112114.
4
The emerging plasticity of SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)新出现的可塑性。
Science. 2021 Mar 26;371(6536):1306-1308. doi: 10.1126/science.abg4493.
5
Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.针对关注的 SARS-CoV-2 变体的中和抗体的表位分类和 RBD 结合特性。
Front Immunol. 2021 Jun 4;12:691715. doi: 10.3389/fimmu.2021.691715. eCollection 2021.
6
Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.SARS-CoV-2 的起源和基因组特征及其与血管紧张素转换酶 2 受体的相互作用,重点关注胃肠道。
World J Gastroenterol. 2020 Nov 7;26(41):6335-6345. doi: 10.3748/wjg.v26.i41.6335.
7
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.ACE2 表达中的遗传变异性对 SARS-CoV-2 刺突 D614G 突变进化动态的影响。
Genes (Basel). 2020 Dec 24;12(1):16. doi: 10.3390/genes12010016.
8
VarEPS-Influ:an risk evaluation system of occurred and virtual variations of influenza virus genomes.VarEPS-Influ:一种流感病毒基因组实际和虚拟变异的风险评估系统。
Nucleic Acids Res. 2024 Jan 5;52(D1):D798-D807. doi: 10.1093/nar/gkad912.
9
Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.针对 SARS-CoV-2 受体结合域的中和抗体,该抗体源自一个原始的人源抗体文库。
Protein Sci. 2021 Apr;30(4):716-727. doi: 10.1002/pro.4044. Epub 2021 Feb 24.
10
Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice.S 蛋白 493 位和 498 位的 Q 突变为 SARS-CoV-2 在小鼠体内的适应性进化提供了条件。
EBioMedicine. 2021 May;67:103381. doi: 10.1016/j.ebiom.2021.103381. Epub 2021 May 14.

引用本文的文献

1
VirusWarn: A mutation-based early warning system to prioritize concerning SARS-CoV-2 and influenza virus variants from sequencing data.病毒预警:一种基于突变的早期预警系统,用于根据测序数据对值得关注的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和流感病毒变体进行优先级排序。
Comput Struct Biotechnol J. 2025 Mar 12;27:1081-1088. doi: 10.1016/j.csbj.2025.03.010. eCollection 2025.
2
Machine Learning Early Detection of SARS-CoV-2 High-Risk Variants.机器学习早期检测新冠病毒高风险变异株
Adv Sci (Weinh). 2024 Dec;11(45):e2405058. doi: 10.1002/advs.202405058. Epub 2024 Oct 14.
3
CovEpiAb: a comprehensive database and analysis resource for immune epitopes and antibodies of human coronaviruses.

本文引用的文献

1
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.最大限度提高广度和耐药逃逸能力的 SARS-CoV-2 RBD 抗体。
Nature. 2021 Sep;597(7874):97-102. doi: 10.1038/s41586-021-03807-6. Epub 2021 Jul 14.
2
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.关注变异株 B.1.427/B.1.429 逃避 SARS-CoV-2 免疫。
Science. 2021 Aug 6;373(6555):648-654. doi: 10.1126/science.abi7994. Epub 2021 Jul 1.
3
Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia.
CovEpiAb:一个关于人类冠状病毒免疫表位和抗体的综合数据库及分析资源。
Brief Bioinform. 2024 Mar 27;25(3). doi: 10.1093/bib/bbae183.
4
RCoV19: A One-stop Hub for SARS-CoV-2 Genome Data Integration, Variant Monitoring, and Risk Pre-warning.RCoV19:一个用于严重急性呼吸综合征冠状病毒2基因组数据整合、变异监测和风险预警的一站式中心。
Genomics Proteomics Bioinformatics. 2023 Oct;21(5):1066-1079. doi: 10.1016/j.gpb.2023.10.004. Epub 2023 Oct 26.
5
VarEPS-Influ:an risk evaluation system of occurred and virtual variations of influenza virus genomes.VarEPS-Influ:一种流感病毒基因组实际和虚拟变异的风险评估系统。
Nucleic Acids Res. 2024 Jan 5;52(D1):D798-D807. doi: 10.1093/nar/gkad912.
6
Applying the digital data and the bioinformatics tools in SARS-CoV-2 research.将数字数据和生物信息学工具应用于2019冠状病毒病研究。
Comput Struct Biotechnol J. 2023 Oct 1;21:4697-4705. doi: 10.1016/j.csbj.2023.09.044. eCollection 2023.
7
A tool to automatically design multiplex PCR primer pairs for specific targets using diverse templates.一种使用多种模板自动设计针对特定靶标的多重 PCR 引物对的工具。
Sci Rep. 2023 Sep 30;13(1):16451. doi: 10.1038/s41598-023-43825-0.
8
The role of SARS-CoV-2 N protein in diagnosis and vaccination in the context of emerging variants: present status and prospects.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核蛋白在新出现变异株背景下的诊断和疫苗接种中的作用:现状与展望
Front Microbiol. 2023 Aug 14;14:1217567. doi: 10.3389/fmicb.2023.1217567. eCollection 2023.
9
Early warning of emerging infectious diseases based on multimodal data.基于多模态数据的新发传染病早期预警
Biosaf Health. 2023 Jun 7;5(4):193-203. doi: 10.1016/j.bsheal.2023.05.006.
10
Web Resources for SARS-CoV-2 Genomic Database, Annotation, Analysis and Variant Tracking.SARS-CoV-2 基因组数据库、注释、分析和变异跟踪的网络资源。
Viruses. 2023 May 12;15(5):1158. doi: 10.3390/v15051158.
用于治疗新冠肺炎肺炎的卡西瑞维单抗和英夫维单抗抗体鸡尾酒疗法的紧急住院给药
Cureus. 2021 May 27;13(5):e15280. doi: 10.7759/cureus.15280.
4
An EUA for sotrovimab for treatment of COVID-19.索托维单抗用于治疗新冠肺炎的紧急使用授权。
Med Lett Drugs Ther. 2021 Jun 28;63(1627):97-xx98.
5
Genome-Wide Variation in Betacoronaviruses.冠状病毒基因组中的变异。
J Virol. 2021 Jul 12;95(15):e0049621. doi: 10.1128/JVI.00496-21.
6
An EUA for bamlanivimab and etesevimab for COVID-19.巴瑞替尼和依替西单抗用于治疗新冠肺炎的紧急使用授权。
Med Lett Drugs Ther. 2021 Apr 5;63(1621):49-50.
7
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.中和抗体LY-CoV555可保护非人类灵长类动物免受SARS-CoV-2感染。
Sci Transl Med. 2021 May 12;13(593). doi: 10.1126/scitranslmed.abf1906. Epub 2021 Apr 5.
8
Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection.新型冠状病毒(SARS-CoV-2)的分子检测正受到病毒变异和无症状感染的挑战。
J Pharm Anal. 2021 Jun;11(3):257-264. doi: 10.1016/j.jpha.2021.03.006. Epub 2021 Mar 26.
9
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.恢复期血清和疫苗血清对 SARS-CoV-2 B.1.1.7 变异株的中和能力降低。
Cell. 2021 Apr 15;184(8):2201-2211.e7. doi: 10.1016/j.cell.2021.02.033. Epub 2021 Feb 18.
10
Computational Mutagenesis at the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Binding Interface: Comparison with Experimental Evidence.严重急性呼吸综合征冠状病毒2刺突蛋白/血管紧张素转换酶2结合界面的计算诱变:与实验证据的比较
ACS Nano. 2021 Apr 27;15(4):6929-6948. doi: 10.1021/acsnano.0c10833. Epub 2021 Mar 18.